Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDGP vs SMILE in Stage III/IV NK/T Cell Lymphoma
NCT01501149Phase 4Unknown
- Start
- Jan 2011
- Primary completion
- Dec 2015
- Modality
- Nanoparticles, Therapeutic Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of Cisplatin micelle injection (HA132), dexamethasone, gemcitabine, pegaspargase in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT). Status: unknown.
02
Drugs
Cisplatin micelle injection (HA132)dexamethasonegemcitabinepegaspargase
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT01501149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01501149.